C1R and glioblastoma: These findings establish the first connection between C1R and mesenchymal characteristics in GBM, suggesting C1R may play a crucial role in the EMT process of GBM and highlighting its potential as a biomarker for mesenchymal GBM and an important target for therapeutic intervention.